Goldman Sachs’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.66M | Buy |
|
|||||
|
2025
Q1 | $6.03M | Buy |
|
|||||
|
2024
Q4 | $8.73M | Sell |
|
|||||
|
2024
Q3 | $11.5M | Buy |
|
|||||
|
2024
Q2 | $9.69M | Sell |
|
|||||
|
2024
Q1 | $7.24M | Buy |
|
|||||
|
2023
Q4 | $2.91M | Sell |
|
|||||
|
2023
Q3 | $2.86M | Buy |
|
|||||
|
2023
Q2 | $3.22M | Sell |
|
|||||
|
2023
Q1 | $4.8M | Sell |
|
|||||
|
2022
Q4 | $6.83M | Sell |
|
|||||
|
2022
Q3 | $10.8M | Buy |
|
|||||
|
2022
Q2 | $4.2M | Buy |
|
|||||
|
2022
Q1 | $4.42M | Buy |
|
|||||
|
2021
Q4 | $8.93M | Buy |
|
|||||
|
2021
Q3 | $3.74M | Sell |
|
|||||
|
2021
Q2 | $7.45M | Sell |
|
|||||
|
2021
Q1 | $10.8M | Buy |
|
|||||
|
2020
Q4 | $5.25M | Buy |
|